MetaShape Pharma to Showcase New Data and Strategic Updates at MedInvest and RESI Life Sciences Investor Conferences
Company to highlight new preclinical data supporting MS 001 as a differentiated GLP-1 co-therapy addressing energy expenditure — the other side of the energy-balance equation MetaShape Pharma AG (“MetaShape” or…